Del Mar, CA – According to filings with the U.S. Securities and Exchange Commission, Radicle Science is raising $6,000,000.00 in new funding. Sources indicate as part of senior management Chief Operating Officer, Ted Roth played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Radicle Science
Radicle Science reimagines the traditional pharmaceutical and academic research model to deliver rigorous health outcome data at a fraction of the time and cost. Our virtual, direct-to-consumer clinical trials offer the first ever path to natural product validation. Radicle Science delivers differentiation and actionable insights by discovering how customers experience your products in the real world as well as in controlled trial settings. Our big data approach offers a unique analysis of demographic or behavioral variations.

To learn more about Radicle Science, visit http://radiclescience.com/

Contact:
Ted Roth, Chief Operating Officer
858-342-4758
ted@radiclescience.com
https://www.linkedin.com/in/ted-roth/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved